In these experiments, Berger and colleagues show that somatic PREX2 mutations identified through whole - genome sequencing of human melanoma can contribute to enhanced lethality
of tumor xenografts in nude mice (Figure 3B, S6B, and S6C; Berger et al., 2012).
Not exact matches
EZH2 inhibition delayed
tumor onset in KDM6A - null cells and caused regression
of KDM6A - null bladder
tumors in both patient - derived and cell line
xenograft models.
We then usually move onto
xenograft models and then also, if available, try to test some
of these compounds in genetically engineered mouse models that have particular mutations driving
tumor formation.
In a 1988 paper summarizing his findings, Fiebig concluded that
xenograft mice were wonderful models for broadly testing new drugs against human
tumors, but they «can not be used as a clinical routine method» for predicting patient treatment.1 The idea
of using
xenograft mice as personal avatars for cancer patients was discarded.
The researchers used an in vivo model
of PARP inhibitor resistance in patient - derived
tumor xenografts (PDXs).
«There is some talk
of going into 3 - D cell models rather than
xenografts, because it is so difficult and challenging to grow [the transplanted
tumors],» says Manish Kohli, the Mayo Clinic oncologist leading the PROMOTE study.
Using 80
of the successful
tumor xenografts — from the Greek «xenos» meaning «foreign» — he compared how the mouse's
tumor responded to a drug or drug combination with the treatment response
of the corresponding human patient.
NCI's efforts to develop new laboratory models
of human cancer includes vastly increasing the number
of human cancer cell lines (grown as two - dimensional and three - dimensional cultures) and patient - derived
tumor xenografts.
Due to the high efficiency
of establishing organoid models from different tissues and diseases, such as cancer, organoid technology allows the generation
of large living biobanks
of tumor organoids that are amenable for middle - throughput drug screens and may allow personalized therapy design, as a complement to cell line and
xenograft - based drug studies (7,19).
Zebrafish larva implanted with cancer patient's
tumor (red) RITA FIOR / CHAMPALIMAUD CENTRE FOR THE UNKNOWNSee R. Fior et al., «Single - cell functional and chemosensitive profiling
of combinatorial colorectal therapy in zebrafish
xenografts,» PNAS, doi: 10.1073 / pnas.1618389114, 2017
Finally, I have a category
of «other cancers» with exomes published in 2011; these include pancreastic cysts and cell lines, gastric cancer
tumors, and prostate cancer samples derived through mouse
xenograft models.
Comparative genomic hybridization showed a normal pattern in the first case and a gain
of chromosomal 12 in the
xenografted tumor.
In a
xenograft KMT2D - mutated T - lymphoma model, dual treatment with chidamide and decitabine significantly retarded
tumor growth and induced cell apoptosis through modulation
of the KMT2D / H3K4me axis.
(G) Immunostaining
of p - ERK in
tumor samples
of xenografted murine models bearing KMT2D V5486 mutants treated with CHID and / or DECI.
In - vivo treatments
of xenografted tumors showed significant
tumor growth inhibition induced either by rituximab or gemcitabine alone and an impressive efficacy
of combined treatment.
In a series
of lab experiments with cell lines, human
xenograft tumors in mice and primary human prostate cancer samples, the researchers demonstrated that miR - 34a inhibits prostate cancer stem cells by suppressing CD44.
It was indeed found DAXX promotes the in vivo tumorigenicity
of two human PCa cell lines in a subcutaneous
tumor xenograft model via suppression
of autophagy [Submitted].
Accordingly, p - ERK upregulation was observed not only in
tumor samples
of PTCL - NOS patients with KMT2D mutations, but also in those
of xenografted T - lymphoma mice bearing KMT2D V5486M mutants, the latter being inhibited by combined treatment with chidamide and decitabine (Figure 5F, G).
We also found that the EphB4 receptor expressed on the surface
of breast cancer cells can promote
tumor xenograft growth by enhancing blood vessel formation through interactions with its preferred ligand, ephrin - B2, present in
tumor endothelial cells.
We have recently reported that the GHRH antagonist, MIA - 602, suppresses the expression
of inflammatory cytokines in human TNBC
tumors xenografted into nude mice.
Intraperitoneal injection
of the HIF - 1α inhibitor, YC1, following
tumor initiation reduces the hypoxic CSC effect in MCF7
xenografts and results in no correlation between
xenograft size and MFC (Fig. 5C).
Confocal fluorescence micrographs
of tumor sections from MCF7 / HER2
xenografts.
On the contrary, recent evidence indicates that XMRV is a contaminant originating from the recombination
of two mouse endogenous retroviruses during passaging
of a prostate
tumor xenograft (CWR22) in mice, generating laboratory - derived cell lines that are XMRV - infected.
A study by Pauli and colleagues in this issue
of Cancer Discovery describes the creation
of a precision cancer platform for patients with advanced disease, integrating DNA sequencing
of patient
tumors with the generation
of patient - derived organoids and
xenografts.
Liu JF, Palakurthi S, Zeng Q, Zhou S, Ivanova E, Huang W, Zervantonakis IK, Selfors LM, Shen Y, Pritchard CC, Zheng M, Adleff V, Papp E, Piao H, Novak M, Fotheringham S, Wulf G, English J, Kirschmeier PT, Velculescu VE, Paweletz CP, Mills GB, Livingston DM, Brugge JS, Matulonis UA, Drapkin R.: Establishment
of patient - derived
tumor xenograft models
of epithelial ovarian cancer for pre-clinical evaluation
of novel therapeutics.
The approach is to use clinically relevant
tumor models such as patient - derived
xenografts (PDXs), as well as humanized and immunocompetent transgenic
tumor - bearing mice to design rational combinations
of novel and emerging cancer therapies, including
tumor - targeting and immune - stimulating therapies, to ultimately improve treatment outcomes for cancer patients.
We next tested the ability
of antibody - expressing NSCs to deliver anti-HER2 antibodies to
tumor foci in vivo using a
xenograft nude - beige mouse model.
Importantly, an inverse correlation was observed for ER - α — negative lines with a decrease in the proportion
of MFC within the
xenograft as
tumor size increases (Fig. 5Bii).
Subcutaneous
tumor cell implantation and purification
of tumor cells from
xenograft tumors.
Autophagy inhibition synergistically enhances anticancer efficacy
of RAMBA, VN / 12 -1 in SKBR - 3 cells, and
tumor xenografts.
This included evaluation
of tumor burden in mice orthotopically
xenografted, as well as analysis
of the overall rate
of survival.
Sulforaphane, a putative anticarcinogen in broccoli, was provided orally to mice bearing androgen - insensitive human PC - 3
xenografts, and resulted in
tumor volumes
of 207 ± 35 and 90 ± 22 mm3 for the control and sulforaphane groups, respectively (22).